Navigating AL Amyloidosis: A Comprehensive Patient Guide
At a Glance
AL amyloidosis is a complex, multi-system disease originating in the bone marrow that can affect major organs like the heart and kidneys. Managing it requires a comprehensive approach, including understanding your pathology, standard of care treatments, and partnering with a multidisciplinary team.
Receiving a diagnosis of AL amyloidosis is often the end of a long, confusing medical journey and the beginning of a new, overwhelming reality. You are not alone, and your feelings of anxiety are completely valid.
This resource guide was created to translate the complex medical data surrounding AL amyloidosis into a strategic, empowering roadmap. Our goal is not to give medical advice, but to equip you with the knowledge and vocabulary you need to partner effectively with your medical team and advocate for the best possible care.
AL amyloidosis is a multi-system disease, which means understanding it requires looking at everything from the biology of your bone marrow to the daily management of your heart and kidney health. We recommend reading through these pages to understand your diagnosis, prepare for your specialist visits, and learn how to monitor your long-term health.
How to Use This Guide
Below, you will find targeted sections that cover every phase of the AL amyloidosis patient journey.
Validation & Orientation: Understanding AL Amyloidosis
Learn what an AL amyloidosis diagnosis means for you. Understand how this rare condition affects your organs, modern treatments like Daratumumab, and next steps.
How AL Amyloidosis Affects Your Body
Learn how AL amyloidosis affects your body. Understand common symptoms of heart, kidney, nerve, and liver involvement, plus red flag signs to watch for.
The Biology of AL Amyloidosis: AL vs. ATTR
Learn the biology of AL amyloidosis, how it differs from ATTR and multiple myeloma, and why accurate typing is critical for your treatment plan.
Diagnosis & Understanding Your Pathology Report
Learn how AL amyloidosis is diagnosed. Understand the blood and urine triple-test, fat pad biopsies, Congo Red staining, and mass spectrometry typing.
Understanding Your Stage and Risk Score
Learn how AL amyloidosis staging works. Understand the Mayo 2004 and 2012 risk scores, key heart biomarkers like NT-proBNP, and what they mean for your care.
Standard of Care Treatment for AL Amyloidosis
Learn about the standard of care treatments for AL amyloidosis, including the Dara-CyBorD regimen, stem cell transplant eligibility, and treatment goals.
Building Your Care Team & First Visit Prep
Learn how to build a multidisciplinary care team for AL amyloidosis. Discover which specialists you need and exactly what to bring to your first appointment.
Survivorship & Long-Term Monitoring
Learn what to expect during AL amyloidosis survivorship. Understand long-term monitoring for sFLC and organ health, daily fluid management, and supportive care.
Remember, you are an intelligent partner in your healthcare. Use the questions provided at the end of each section to guide your self-reflection and direct your conversations with your doctors.
Common questions in this guide
How does AL amyloidosis affect the body?
What kind of doctors should be on my AL amyloidosis care team?
What is the difference between AL and ATTR amyloidosis?
Why is it important to monitor my daily weight with AL amyloidosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many AL amyloidosis patients do you and your team treat annually?
- 2.Will my care be actively coordinated among a multidisciplinary team, including a cardiologist or nephrologist?
- 3.What is the best way to contact the clinic if I experience sudden side effects or a rapid change in my daily weight?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
This guide provides educational information to help you navigate an AL amyloidosis diagnosis. It is not intended to replace professional medical advice, diagnosis, or treatment from your multidisciplinary care team.
Get notified when new evidence is published on AL amyloidosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.